Avricore Health Inc.

PNK:AVCRF

$0.0387 USD

$0.0 (-7.86%)

Volume
30K
Average Volume
40.76K
Market Capitalization
$3.92M
P/E Ratio
-2395.00
Dividend Yield
0.00%
Price Target
$
Year High
$0.25
Year Low
$0.04
Payout Ratio
$0.00
Current Ratio
$2.79

Industry, Sector & symbol

Stock Exchange Other OTC
CEO Mr. Hector Bremner
Industry Medical - Diagnostics & Research
Sector Healthcare
Current Symbol AVCRF
CUSIP 054521109
CIK 0001355736
Web https://www.avricorehealth.com
Phone None
Currency USD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio 0.00
Payout Ratio 0.00
Current Ratio 2.79
Quick Ratio 2.76
Cash Ratio 1.63

Sales & Book Value

Annual Sales $3.49M
Price / Sales 1.58
Cash Flow 0.00
Price / Cash Flow 73.37
Price / Book 3.07

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.007
Trailing P/E Ratio -2395.00
PEG Ratio -24.65
P/E Growth -24.65
Net Income $-701.22K
Net Margin -0.07%
Pretax Margin -0.07%
Return on Equity -0.14%
Return on Assets -0.11%

Financials Score

AltmanZ Score -7.96
Piotroski Score 4.00
Working Capital 609.11K
Total Assets 2.62M
Ebit 2.86K
Market Cap 3.92M
Total Liabilities 341.18K

Poll Results

About Avricore Health Inc. (PNK:AVCRF) Stock

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a lab-accurate point of care testing platform for pharmacy. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. ...

Avricore Health Corporate Update: Effective Plan, Resources Result in Success

2024-11-29 07:30:00

VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its third quarter results for 2024 where the Company continues to see rising revenues and profitability.

Avricore Health Refocuses Strategy to Unlock Growth Potential

2024-11-14 18:01:00

VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR) ("Avricore" or the "Company"), a leader in pharmacy-based point-of-care testing solutions, today announces a strategic shift to increase its focus on the rapidly expanding UK healthcare market and begin concluding its Canadian pharmacy partnership with Shoppers Drug Mart. This shift in market development builds on the UCL Partners announcement of its rapid cholesterol initiative in community pharmacies in North East London.

Avricore Health Recognized in Deloitte's 2024 Technology Fast 50™ Companies to Watch

2024-11-06 15:14:00

VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR), a leader in pharmacy-based health technology solutions, proudly announces its placement in Deloitte Canada's 2024 Technology Fast 50™ Companies-to-Watch category, securing the 8th position with an impressive growth rate of 2738%. This award acknowledges Avricore's pioneering work in real-time data and health testing through its platform, HealthTab™, which empowers pharmacies to support patient health outcomes effectively.

Avricore Grants Options

2024-08-30 21:29:00

VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces that the Company's board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 3,361,000 common shares to its directors, officers, employees and consultants at an exercise price of CAD $0.29 per common share.

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

2024-08-29 06:05:00

VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its mid-year results for 2024 demonstrating the Company's continued success in maintaining strong growth in revenues while achieving net profitability.

Frequently Asked Questions

What is the current Avricore Health Inc. (AVCRF) stock price?

Avricore Health Inc.(PNK:AVCRF) stock price is $0.0387 in the last trading session. During the trading session, AVCRF stock reached the peak price of $0.2539 while $0.0379 was the lowest point it dropped to. The percentage change in AVCRF stock occurred in the recent session was --7.86% while the dollar amount for the price change in AVCRF stock was -$-0.0.

AVCRF's industry and sector of operation?

The PNK listed AVCRF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of AVCRF?

Ms. Kiriaki Smith CPA, CFO, CGA, CPA | Chief Financial Officer & Corporate Secretary
Mr. Hector Bremner | Chief Executive Officer & Director
Mr. Rodger Seccombe | Chief Technology Officer & Director
Mr. Will Seccombe | Communications Advisor
|

How many employees does AVCRF have?

Number of AVCRF employees currently stands at None. AVCRF operates from 789 West Pender Street, Vancouver, BC V6C 1H2, CA.

Link for AVCRF official website?

Official Website of AVCRF is: https://www.avricorehealth.com

How do I contact AVCRF?

AVCRF could be contacted at phone #None and can also be accessed through its website. AVCRF operates from 789 West Pender Street, Vancouver, BC V6C 1H2, CA.

How many shares of AVCRF are traded daily?

The average number of AVCRF shares traded daily for last 3 months was 40.76K.

What is the market cap of AVCRF currently?

The market value of AVCRF currently stands at $3.92M with its latest stock price at $0.0387